CD86 and neoplasm: Mice receiving adjuvant NIPP treatment after surgical resection of orthotopic breast cancer tumors showed an increased percentage of mature CD86+ and CD80+ DCs in tumor-draining lymph nodes, and increased numbers of tumor-infiltrating CD4+ and CD8+ T cells.